Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
about
Patient preferences in advanced or recurrent ovarian cancer.Incorporating clinical trial data into daily cancer care.Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.Safety and preliminary efficacy analysis of the mTOR inhibitor ridaforolimus in patients with taxane-treated, castration-resistant prostate cancer.Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.Pitfalls in outcome prediction of breast cancer.Patient-reported outcomes as end points and outcome indicators in solid tumours.Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review.Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: progress, challenges and reflections.Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.
P2860
Q27336251-AA52999A-75A0-4503-BE95-F98CA65B2467Q30836868-8A0B8C19-4EB5-4B94-B396-F4E02B22FE16Q33729389-BE8F52CC-9520-42EC-95F5-7AC1B1197EAEQ37558947-438EEF49-B05E-460E-B80F-4A5BC33C987AQ37658520-EEDF2316-39CA-49BD-834E-68C445BC0588Q38055499-E7D1ECE0-CD39-4081-96FF-75EC73331330Q38101747-B4AD1C86-903B-4045-9F9C-23C4E17827A8Q38371340-3A8DEAED-2549-4669-8720-137D46E7FCC0Q38555581-194BFB24-A1CB-4EA6-8EF1-9408D7343D79Q47206742-46643B82-28AC-43B5-85CD-F0992A877B7EQ48037262-9562959C-0261-4A03-A52E-ED2EA7173B8C
P2860
Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@en
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@nl
type
label
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@en
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@nl
prefLabel
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@en
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@nl
P2093
P1476
Clinical benefit in oncology t ...... d or tumour-centred end-point?
@en
P2093
Christopher M Booth
Elizabeth A Eisenhauer
Pavlo Ohorodnyk
P304
P356
10.1016/J.EJCA.2009.05.033
P577
2009-06-21T00:00:00Z